RxSight Inc (NASDAQ: RXST) started the day on Wednesday, with a price decrease of -3.54% at $48.51, before settling in for the price of $50.29 at the close. Taking a more long-term approach, RXST posted a 52-week range of $20.66-$66.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 201.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.04%. This publicly-traded company’s shares outstanding now amounts to $39.68 million, simultaneously with a float of $37.66 million. The organization now has a market capitalization sitting at $1.92 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.93, while the 200-day Moving Average is $52.61.
RxSight Inc (RXST) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. RxSight Inc’s current insider ownership accounts for 5.11%, in contrast to 82.59% institutional ownership. According to the most recent insider trade that took place on Oct 22 ’24, this organization’s insider sold 3,100 shares at the rate of 49.68, making the entire transaction reach 154,001 in total value, affecting insider ownership by 42,246.
RxSight Inc (RXST) Earnings and Revenue Records
RxSight Inc’s EPS increase for this current 12-month fiscal period is 42.04% and is forecasted to reach -0.53 in the upcoming year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
Let’s observe the current performance indicators for RxSight Inc (RXST). It’s Quick Ratio in the last reported quarter now stands at 13.34. The Stock has managed to achieve an average true range (ATR) of 1.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.71.
In the same vein, RXST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.01, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.53 at the market close of one year from today.
Technical Analysis of RxSight Inc (RXST)
If we take a close look at the recent performances of RxSight Inc (NASDAQ: RXST), its last 5-days Average volume was 0.32 million that shows plunge from its year to date volume of 0.47 million. During the previous 9 days, stock’s Stochastic %D was recorded 47.48% While, its Average True Range was 1.67.
Raw Stochastic average of RxSight Inc (RXST) in the period of the previous 100 days is set at 47.12%, which indicates a major rise in contrast to 25.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 24.74% that was lower than 48.93% volatility it exhibited in the past 100-days period.
